PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
18-Mar-2026 Crossbow Therapeutics Raises $77 Million in Series B Financing to Advance Development of TCR-mimetic Antibody Therapies to Treat Cancer Businesswire
18-Mar-2026 Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Businesswire
18-Mar-2026 Newron Announces Nominations to Its Board of Directors at Upcoming Annual General Meeting Businesswire
18-Mar-2026 Leveragen Announces Collaboration with Daiichi Sankyo to Support Development of Advanced Biologics Using Next-Gen In Vivo Antibody Discovery Platforms Businesswire
18-Mar-2026 ClearNote Health Appoints Jeffrey Venstrom, MD, as Chief Medical Officer and Expands Leadership Team to Drive Clinical Adoption of Early Cancer Detection Tests Businesswire
18-Mar-2026 Astro Pak LLC Completes Acquisition of Clean Sciences Businesswire
18-Mar-2026 Excalipoint Therapeutics Launches with $68.7 Million to Develop Next-Generation T-Cell Engager Therapies Businesswire
18-Mar-2026 TriSalus Life Sciences Announces Publication Demonstrating Enhanced Delivery and Immune Activation with Nelitolimod Delivered with Pressure-Enabled Drug Delivery in Liver Tumor Models Businesswire
18-Mar-2026 Infinity Bio Appoints Brian McKelligon as Chief Executive Officer Businesswire
18-Mar-2026 Coya Therapeutics Announces Publication Demonstrating Regulatory T-Cell Dysfunction and Systemic Inflammation in Frontotemporal Dementia, Supporting Mechanistic Rationale for COYA 302 Immune-Restoring Therapy Businesswire
18-Mar-2026 Enveric Biosciences Announces Registration of Five Trademarks Businesswire
18-Mar-2026 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
18-Mar-2026 Mirecule Expands Strategic FSHD Collaboration with Sanofi Businesswire
18-Mar-2026 Bicycle Therapeutics Announces Oral and Poster Presentations at the AACR Annual Meeting 2026 Businesswire
18-Mar-2026 KalVista Pharmaceuticals to Report Eight Months Fiscal Year 2025 Financial Results and Provide Corporate Update on March 25, 2026 Businesswire
18-Mar-2026 Pelage Pharmaceuticals’ PP405 and its Impact on Follicular Regeneration to be Presented at the American Academy of Dermatology (AAD) Annual Meeting 2026 Businesswire
18-Mar-2026 Ferrer Included in the Ranking of the World’s Most Ethical Companies® in 2026 Businesswire
18-Mar-2026 ProImmune and the Roslin Institute Collaborate to Advance Animal Health Science Businesswire
18-Mar-2026 Genoskin Showcases HypoSkin® Ex Vivo Platform at SOT Annual Meeting Andrew Lloyd Associates
18-Mar-2026 Inocras and Broad Institute Researchers Will Release Novel Insights From TCGA Cancer Whole-Genome Analysis at AACR Annual Meeting 2026, Empowering a New Era of Precision Oncology Businesswire